| 88976-6 |
Leukocyte casts |
Naric |
Urine sed |
Pt |
Qn |
|
|
ACTIVE |
WBC casts [#/area] in Urine sediment |
|
ADD |
DefinitionDescription |
|
|
/LPF |
|
|
|
|
|
|
UA |
|
88976-6 |
|
|
|
|
Observation |
|
|
|
0 |
WBC Casts #/area UrnS |
|
|
|
|
|
#/area; Cast; Kidney; Leuc; Leuk; Leukocytes; Lkcs; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBC Casts; WBCs; White blood cell; White blood cells |
2.64 |
2.64 |
|
|
|
|
|
|
|
/[LPF] |
|
|
|
0 |
| 88977-4 |
Epithelial casts |
Naric |
Urine sed |
Pt |
Qn |
|
|
ACTIVE |
Epithelial casts [#/area] in Urine sediment |
|
ADD |
DefinitionDescription |
|
|
/LPF |
|
|
|
|
|
|
UA |
|
88977-4 |
|
|
|
|
Observation |
|
|
|
0 |
Epith Casts #/area UrnS |
|
|
|
|
|
#/area; Cast; Epi; Epith; Epith Casts; Epithelia; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.64 |
2.64 |
|
|
|
|
|
|
|
/[LPF] |
|
|
|
0 |
| 88978-2 |
Fat |
PrThr |
Urine sed |
Pt |
Ord |
|
|
ACTIVE |
Fat [Presence] in Urine sediment |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
UA |
|
88978-2 |
|
|
|
|
Observation |
|
|
|
0 |
Fat UrnS Ql |
|
|
|
|
|
Kidney; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88979-0 |
Mucus |
PrThr |
Urine sed |
Pt |
Ord |
|
|
ACTIVE |
Mucus [Presence] in Urine sediment |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
UA |
|
88979-0 |
|
|
|
|
Observation |
|
|
|
0 |
Mucous Threads UrnS Ql |
|
|
|
|
|
Kidney; Mucous; Mucous Threads; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 8898-9 |
Arterial pulse intensity |
Force |
Brachial artery.left |
Pt |
Ord |
Palpation |
|
ACTIVE |
Pulse intensity Brachial artery - left by palpation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HRTRATE.MOLEC |
|
8898-9 |
|
Palpation |
|
|
|
|
|
|
0 |
Pulse intensity Brach a-L Palpation |
|
|
|
|
|
Art; Brach a; Brach a-L; Cardio; Cardiology; Heart Disease; Heart Rate; HEART RATE.MOLEC; L; LT; Mechanical force; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Upper arm |
2.38 |
1.0h(3) |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88980-8 |
Swollen joint |
Num |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Swollen joint # |
|
ADD |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
SURVEY.GNHLTH |
|
88980-8 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH |
2.64 |
2.64 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
| 88981-6 |
Tender joint |
Num |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Tender joint # |
|
ADD |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
SURVEY.GNHLTH |
|
88981-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH |
2.64 |
2.64 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
| 88982-4 |
Rheumatoid arthritis disease activity level |
Imp |
^Patient |
Pt |
Ord |
CDAI |
|
ACTIVE |
Rheumatoid arthritis disease activity level [CDAI] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
88982-4 |
|
CDAI |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Activ; Actvty; Arth; Clinical Disease Activity Index; Dis; Diseases; Dz; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Levels; Levl; LV; LVL; MDAS; Movements; Multi-biomarker disease activity score; Ordinal; Point in time; QL; Qual; Qualitative; RA; Random; Screen; Survey; SURVEY.GNHLTH |
2.65 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88983-2 |
Tender joint |
Anat |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Tender joint |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
88983-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Anatomy; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88984-0 |
Swollen joint |
Anat |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Swollen joint |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
88984-0 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Anatomy; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88985-7 |
Alpha-amanitin+gamma-amanitin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88985-7 |
|
|
|
|
Both |
|
|
|
0 |
Alpha+gamma-amanitin SerPl-mCnc |
|
|
|
|
|
Alfa; Alpha+gamma-amanitin; Amanitin phalloides syndrome; Deadly mushroom toxin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.64 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88986-5 |
Elvitegravir |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Elvitegravir [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88986-5 |
|
|
|
|
Both |
|
|
|
0 |
Elvitegravir SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; EVG; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.64 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88987-3 |
Maraviroc |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Maraviroc [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88987-3 |
|
|
|
|
Both |
|
|
|
0 |
Maraviroc SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.64 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88988-1 |
Melperone |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Melperone [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88988-1 |
|
|
|
|
Both |
|
|
|
0 |
Melperone SerPl-mCnc |
|
|
|
|
|
Bunil; Buronil; DRUG/TOXICOLOGY; Drugs; Eunerpan; Level; Mass concentration; Melperon; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.65 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88989-9 |
Perazine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Perazine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88989-9 |
|
|
|
|
Both |
|
|
|
0 |
Perazine SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Perazin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Taxilan |
2.65 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 8899-7 |
Arterial pulse intensity |
Force |
Brachial artery.right |
Pt |
Ord |
Palpation |
|
ACTIVE |
Pulse intensity Brachial artery - right by palpation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HRTRATE.MOLEC |
|
8899-7 |
|
Palpation |
|
|
|
|
|
|
0 |
Pulse intensity Brach a-R Palpation |
|
|
|
|
|
Art; Brach a; Brach a-R; Cardio; Cardiology; Heart Disease; Heart Rate; HEART RATE.MOLEC; Mechanical force; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Upper arm |
2.38 |
1.0h(3) |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88990-7 |
Sertindole |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Sertindole [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88990-7 |
|
|
|
|
Both |
|
|
|
0 |
Sertindole SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serdolect; Serlect; SerP; SerPl; SerPlas; Sertindol; Serum; Serum or plasma; SR |
2.65 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88991-5 |
Zotepine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Zotepine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88991-5 |
|
|
|
|
Both |
|
|
|
0 |
Zotepine SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Lodopin; Losizopilon; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Setous; SR; Zoleptil; Zotepin |
2.65 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88992-3 |
Ustekinumab Ab |
MCnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Ustekinumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88992-3 |
|
IA |
|
|
Both |
|
|
|
0 |
Ustekinumab Ab SerPl IA-mCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; STELARA�®; SUDS |
2.73 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88993-1 |
Acute kidney injury risk |
Likelihood |
^Patient |
Pt |
Qn |
Calculated.NephroCheck |
|
ACTIVE |
Acute kidney injury risk [Likelihood] by Calculated by NephroCheck |
|
MIN |
DefinitionDescription |
|
|
risk |
|
|
(|TIMP-2|*|IGFBP-7|)/1000 |
|
|
|
CHEM |
|
88993-1 |
|
Calculated.NephroCheck |
|
|
Both |
|
|
|
0 |
Acute kidney injury risk NephroCheck |
|
|
|
|
|
Acute Renal Failure; AKI risk; ARF; Calc; Calc.NephroCheck; Calculation; Chemistry; NephroCheck test system; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Ulcer |
2.69 |
2.64 |
|
|
|
|
|
|
|
{risk} |
|
|
Release 2.69: FORMULA: Corrected formula from (|TIMP-2|*|IGFBP-7|)^2/1000 (the ^2 was incorrect).; |
0 |
| 88994-9 |
Arachidonate/Fatty acids.C14-C24 |
SFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Arachidonate (C20:4w6)/Fatty acids.C14-C24 in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
88994-9 |
|
|
|
|
Both |
|
|
|
0 |
AA/Fatty acids.C14-C24 SFr SerPl |
|
|
|
|
|
5,8,11,14 Eicosatetraenoic acid; AA; Acd; Acid; Arachidonic acid; Arch acid; C20:4w6; Chemistry; Eicosatetraenoate; Fatty acid; Lipid; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction |
2.73 |
2.64 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 88995-6 |
Docosahexaenoate/Fatty acids.C14-C24 |
SFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Docosahexaenoate (C22:6w3)/Fatty acids.C14-C24 in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
88995-6 |
|
|
|
|
Both |
|
|
|
0 |
DHA/Fatty acids.C14-C24 SFr SerPl |
|
|
|
|
|
Acd; Acid; C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Fatty acid; Lipid; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction |
2.73 |
2.64 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 88996-4 |
Eicosapentaenoate/Arachidonate |
SRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Eicosapentaenoate (C20:5w3)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
molar ratio |
|
|
|
|
|
|
CHEM |
|
88996-4 |
|
|
|
|
Both |
|
|
|
0 |
EPA/AA SerPl-sRto |
|
|
|
|
|
5,8,11,14 Eicosatetraenoic acid; AA; Arachidonic acid; Arch acid; C20:4w6; C20:5w3; Chemistry; Eicosapentaenoic acid; Eicosatetraenoate; EPA; Icosapentaenoate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; Timnodonate; Timnodonic Acid |
2.73 |
2.64 |
|
|
|
|
|
|
|
mol/mol |
|
|
|
0 |
| 88997-2 |
Eicosapentaenoate/Fatty acids.C14-C24 |
SFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C24 in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
88997-2 |
|
|
|
|
Both |
|
|
|
0 |
EPA/Fatty acids.C14-C24 SFr SerPl |
|
|
|
|
|
Acd; Acid; C20:5w3; Chemistry; Eicosapentaenoic acid; EPA; Fatty acid; Icosapentaenoate; Lipid; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Timnodonate; Timnodonic Acid |
2.73 |
2.64 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 88998-0 |
Eicosapentaenoate+Docosahexaenoate/Fatty acids.C14-C24 |
SFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Omega-3 (EPA+DHA) index in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
88998-0 |
|
|
|
|
Both |
|
|
|
0 |
Omega-3 index SFr SerPl |
|
|
|
|
|
Acd; Acid; C20:5w3; C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Eicosapentaenoic acid; EPA; EPA+DHA; Fatty acid; Icosapentaenoate; Lipid; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Timnodonate; Timnodonic Acid |
2.73 |
2.64 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
